ALLO vs AMGN: Which Stock is Better?
Side-by-side comparison of Allogene Therapeutics Inc and Amgen Inc in 2026
ALLO
Allogene Therapeutics Inc
$2.15
AMGN
Amgen Inc
$349.92
Key Metrics Comparison
| Metric | ALLO | AMGN | Winner |
|---|---|---|---|
| Market Cap | $510.14M | $189.47B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.23 | AMGN |
| Revenue Growth | -1.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze ALLO
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALLO or AMGN a better investment?
Comparing ALLO and AMGN: Allogene Therapeutics Inc has a market cap of $510.14M while Amgen Inc has $189.47B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALLO and AMGN?
ALLO (Allogene Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALLO or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALLO or AMGN?
AMGN has higher revenue growth at 0.1% vs -1.0% for ALLO.
Which company is more profitable: ALLO or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for ALLO.
Which is the larger company: ALLO or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.47B compared to $510.14M for ALLO.
Should I buy ALLO or AMGN in 2026?
Both ALLO and AMGN have investment merit. ALLO trades at $2.15 while AMGN trades at $349.92. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALLO and AMGN stock?
Key differences: Market Cap ($510.14M vs $189.47B), P/E Ratio (N/A vs 24.7x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).